Immune-Onc Therapeutics - Business-News-Today.com

🚀 Building a website? Start with reliable WordPress hosting from MilesWeb →

Business news, market intelligence, and global industry analysis.

The Latest

Nexsen (ASX: NXN) jumps as StrepSure validation path sharpens

Novartis agrees $1.5bn Myricx Bio deal as ADC platform race intensifies

Knights Group revenue jumps 28% as KGH organic growth accelerates to 12%

Genesis Minerals (ASX: GMD) launches A$5.6bn Vault bid as Regis faces five-day test

FDA Grants Orphan Drug Designation to Immune-Onc Therapeutics IO-202 for CMML Treatment

Read More

Pharma Industry News

Immune-Onc Therapeutics gets FDA orphan drug status for IO-202 in CMML

Immune-Onc Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies in immunology and oncology,…

byPallavi Madhiraju

February 22, 2024

web analytics